On other hand, berberine could ameliorate diabetes-associated cognitive decline and hepatic ischemia/reperfusion injury via down-regulating PI3K/Akt/mTOR signaling pathway (Sheng et al., 2015; Chen et al., 2017). The gene discussed is AKT1; the disease is diabetes mellitus.